MMI's Symani surgical robot used in first U.S. clinical cases
MMI announced the reconstructive extremity microsurgeries a month after winning FDA de novo classification for its Symani surgical robot.
Stay updated with breaking news from Mark Toland. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MMI announced the reconstructive extremity microsurgeries a month after winning FDA de novo classification for its Symani surgical robot.
Medical Microinstruments announced today that the FDA granted de novo clearance for its Symani surgical robot platform.
Not every actor wants fans to know about their soap opera backgrounds.
MMI Medical Microinstruments Inc. a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions today announced that it has raised 110 million in Series C financing.
Medical Microinstruments announced today that it raised $110 million in a Series C financing round to help commercialize its surgical robot.